Fed. Circ. Affirms PTAB Nix Of Depomed Drug-Release Patent
The Federal Circuit on Tuesday affirmed the U.S. Patent and Trial Appeal Board's decision in an America Invents Act inter partes review that Depomed's patent on extended-release drug technology is invalid...To view the full article, register now.
Already a subscriber? Click here to view full article